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Abstract
Cyclic ADP-ribose and NAADP are ubiquitous calcium mobilizing messengers produced by the same family of multifunctional
enzymes, the ADP-ribosyl cyclases. Not all ADP-ribosyl cyclases have been identified and how production of different messengers is
achieved is incompletely understood. Here, we report the cloning and characterization of a novel ADP-ribosyl cyclase (SpARC4) from
the sea urchin, a key model organism for the study of calcium signalling pathways. Like several other members of the ADP-ribosyl
cyclase superfamily, SpARC4 is a glycoprotein targeted to the plasma membrane via a GPI anchor. However, unlike most other
members, SpARC4 shows a remarkable preference for producing cyclic ADP-ribose over NAADP. Mutation of a single residue
(tyrosine 142) within a non-canonical active site reversed this striking preference. Our data highlight further diversification of this
unusual enzyme family, provide mechanistic insight into multifunctionality and suggest that different ADP-ribosyl cyclases are fine
tuned to produce specific calcium mobilizing messengers.
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derivatives ; metabolism ; Sequence Homology, Amino Acid ; Strongylocentrotus purpuratus ; enzymology ; genetics ; metabolism ; Transfection ; Tyrosine ; genetics ; 
metabolism ; Xenopus laevis ; embryology
Changes in cytosolic calcium levels govern a multitude of cellular processes. Many extracellular stimuli mediate complex changes in
calcium through production of second messengers ( ). These molecules effect release of calcium from intracellular stores. In addition to1 
inositol 1,4,5-trisphosphate, both cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) play critical
roles in the generation of agonist-evoked calcium signals ( ; ). cADPR releases calcium through activation of the ryanodine receptors2 3 
located on endoplasmic reticulum stores ( ; ). The mechanism of action of NAADP is less certain ( ) although in sea urchin eggs, where2 4 5 
its effects were discovered ( ), it is clear that NAADP acts on novel calcium-permeable channels located not on the endoplasmic6 
reticulum, but instead on acidic lysosomal-like stores ( ). These channels have recently been identified as the two-pore channels (7 –9 10 –
). Remarkably, both cADPR and NAADP are synthesized by the same family of enzymes, the ADP-ribosyl cyclases ( ; ), which12 13 14 
therefore play a central role in calcium signalling and have been implicated in a variety of processes ranging from bacterial clearance ( )15 
to social behaviour ( ).16 
ADP-ribosyl cyclase activity was originally identified in sea urchin egg homogenates ( ) but an enzyme with this activity was later17 
purified ( ) and cloned ( ) from ovotestes. This enzyme was shown to catalyze the cyclization of NAD to form18 19 Aplysia californica 
cADPR ( ; ) and the replacement of the nicotinamide moiety in NADP with nicotinic acid, to form NAADP ( ). Based on sequence18 20 21 
similarity, it became evident that the mammalian proteins, CD38 ( ) and CD157 ( ) were also ADP-ribosyl cyclases. More recently 22 23 
NACE ( ), a homologue from the blood fluke , and an expanded family of three ADP-ribosyl cyclasesSm 24 Schistosoma mansoni 
(SpARC1-3) from the sea urchin ( ) have been identified. Somewhat paradoxically, many members of the ADP-ribosyl cyclase family25 
including CD38, the most extensively studied, are located predominantly on the cell surface and therefore away from their cytosolic
substrates ( ; ). This topological barrier however is circumvented through identified transporter molecules that mediate both substrate13 14 
efflux and product influx across the plasma membrane ( ). Recent studies have also shown that members of the sea urchin ADP-ribosyl26 
cyclase family are present within intracellular organelles where again they are able to access cytosolic substrates through presumed
transporters ( ; ). ADP-ribosyl cyclase also appears to localize to cytoplasmic organelles in eggs ( ) and has been shown25 27 Aplysia 18 
more recently to undergo redistribution from the cytoplasm to the nucleus upon depolarisation in neurons ( ). Targeting of ADP-ribosyl28 
cyclase to different subcellular locales may therefore result in localised production of calcium mobilizing messengers which may
contribute to the production of spatially restricted calcium signals.
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Reduced cellular levels of cADPR ( ; ; ) and NAADP ( ) in certain tissues from CD38-knockout mice underscore the15 29 30 31 
physiological importance of this ADP-ribosyl cyclase in generating calcium mobilizing messengers . Such analyses have alsoin vivo 
highlighted the likely existence of novel ADP-ribosyl cyclases in tissues such as the brain ( ) and uterus ( ) where messenger levels32 33 
appear to be unperturbed in these animals. Indeed several novel activities ( ) including a soluble enzyme in sea urchin eggs ( )34 –43 44 
have been described for which molecular correlates are currently lacking. It appears therefore that not all ADP-ribosyl cyclases have been
described yet at the molecular level.
ADP-ribosyl cyclases show only modest sequence similarity (30 40 ). However, their overall 3-D structures, where known, are– %
almost identical ( ). The active site has been defined for both ADP-ribosyl cyclase ( ) and CD38 ( ) in which a highly45 –47 Aplysia 48 49 
conserved glutamate is likely the catalytic residue. Despite this conservation in 3D-structure, ADP-ribosyl cyclases show remarkable
differences in their catalytic properties. For example, ADP-ribosyl cyclase produces primarily cADPR from NAD ( ; )Aplysia 18 20 
whereas, in contrast, CD38 possesses robust NAD glycohydrolase activity ( ) thereby producing predominantly ADP-ribose and only22 
modest amounts of cADPR (2 3  of reaction products). Additionally, CD38 is capable of hydrolyzing cADPR directly to ADP-ribose,– %
whereas ADP-ribosyl cyclase is comparatively a very poor cADPR hydrolase ( ; ; ). Notably, ADP-ribose also modulatesAplysia 13 14 50 
calcium fluxes through regulation of the TRP channel, TRPM2 present in the plasma membrane ( ) and possibly also on lysosomal51 
calcium stores ( ; ). Further differences in catalytic activity of ADP-ribosyl cyclases are evident with the surrogate substrate, NGD (52 53 54
). Both NACE ( ) and SpARC1 ( ) although able to cyclize NGD to cGDPR, produce much less cADPR from NAD ( ) thanSm 24 25 24 
CD38 whereas SpARC2 ( ) and several unidentified mammalian ADP-ribosyl cyclases ( ; ; ) are unable to cyclize NGD.55 32 36 39 
Understanding the molecular basis for such unprecedented differences in catalysis represents a key challenge that will ultimately aid in
understanding the functions of these enzymes . Intriguingly, although glycohydrolase activity is very low for ADP-ribosylin vivo Aplysia 
cyclase using the natural substrate, NAD, this activity is unmasked by the introduction into its structure of an additional cystine pair, as
found in CD38 ( ), and also by using a fluorinated analogue of NAD that cannot be cyclized ( ). NAD glycohydrolase activity can also56 57 
be readily detected in ADP-ribosyl cyclase upon mutation of phenylalanine 174 which together with the associated reduction inAplysia 
cyclase activity results in a mutant enzyme displaying properties reminiscent of CD38 ( ). Conversely, mutation of the corresponding58 
residue (threonine 221) in CD38 increases cyclase activity at the expense of NAD glycohydrolase activity. Indeed, the concomitant
mutation of this residue and of glutamate 146, a residue previously implicated in determining the cyclase/NAD glycohydrolase ratio ( ),59 
results in a catalytic profile very similar to that of ADP-ribosyl cyclase including poor cADPR hydrolase activity ( ).Aplysia 58 
Mutagenesis of the NACE has also resulted in the identification of a single residue that increases ADP-ribosyl cyclase activity ( ).Sm 60 
Although ADP-ribosyl cyclases are capable of synthesis of both cADPR and NAADP, how messenger production is controlled in vivo
is not clear. It is possible that the activities of the same enzyme may be differentially regulated. Alternatively, different homologues may
be endowed with different relative activities. Here we report the molecular cloning of SpARC4, a novel member of the ADP-ribosyl
cyclase family from the sea urchin and show that this protein is a GPI-anchored plasma membrane glycoprotein capable of synthesising
both cADPR and NAADP. In contrast to other ADP-ribosyl cyclases, and in analogy with the enzyme, SpARC4 preferentiallyAplysia 
produces cADPR. We identify a unique acidic-basic cluster of amino acids within the N-terminus and a non-conserved tyrosine residue
within the active site. Whereas manipulation of the former had little impact on catalysis, tyrosine 142 was found to control the relative
production of cADPR and NAADP such that its mutation was sufficient to convert SpARC4 into an enzyme that preferentially produces
NAADP.
METHODS
Molecular cloning of SpARC4
The sequences of the primers used are listed in . Total RNA was isolated from prism stage (46 h) embryos of Table S1 
using the RNeasy kit (Qiagen), according to manufacturer s instructions. The samples were treated withStrongylocentrotus purpuratus ’
DNase to eliminate any genomic DNA contamination. First strand cDNA synthesis was performed using the Improm-II kit (Promega) and
either gene-specific primer 1R (for 5 -RACE) or oligo (dT) adaptor primers (for 3 -RACE). Typical reactions (40 l) contained 2 g′ 17 ′ μ μ
RNA. For 5 -RACE, the polyA tailing reaction was performed using terminal transferase (Promega) as per the manufacturer s instructions.′ ’
Nested PCR was performed using the oligo (dT) adaptor or adaptor primer as the forward primers with the gene-specific reverse primers17 
3R or 2R, respectively. A 750 bp product was amplified and sequenced. This extended the 5 -sequence to an in frame stop codon. For 3′ ′
-RACE, PCR was performed using the nested gene-specific forward primers 1F and 2F together with the adaptor primer as the reverse
primer. A 850 bp product was amplified, which extended the 3 -sequence to an in-frame stop codon. All the above gene-specific primers′
were based on genomic contig 640882 identified by an initial BLAST search of the genome sequencingStrongylocentrotus purpuratus 
project at the Baylor College of Medicine ( ) with the ADP-ribosylhttp://www.hgsc.bcm.tmc.edu/projects/seaurchin/ Aplysia californica 
cyclase sequence (accession number: ). An additional pair of gene-specific primers 6F and 3  UTR 1R were designed on theP29241 ′
sequences obtained by RACE and used to amplify the full-length coding sequence  54 bp of 3 -UTR of SpARC4. The 1089 bp product+ ′
was cloned into pCR II-TOPO (Invitrogen) and sequenced in both directions. The sequence was deposited at EMBL under the accession ®  ®
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number FN645665. All PCRs were performed using Platinum Hi-fidelity Taq DNA polymerase enzyme (Invitrogen) and 35 cycles of
denaturation (30 sec at 94 C) annealing (30 sec at 50 C) and extension (1 min at 68 C) following an initial denaturation step (2 min at 94° ° ° °
C).
Plasmids
A plasmid encoding untagged SpARC4 was generated by amplification of the full-length coding sequence using primers 7F and 6R
followed by cloning of the product into pCS2  at the EcoRI and XbaI sites. Plasmids encoding for SpARC4, tagged at their N termini with+
6 tags, were generated by cloning products in to the EcoRI and XbaI sites of pCS2  MT into which the sequence corresponding to themyc +
signal peptide of SpARC2 (residues 1 23) had been inserted upstream of the tags at the BamHI and ClaI sites ( ). Full-length– myc 25 
(mature) SpARC4 (SpARC4 ) was generated by inserting the product amplified using primer N-Myc 1F and 6R corresponding tomyc 
amino acids 39 to 343. SpARC4 lacking the C-terminal 17 amino acids (SpARC4 C myc) was generated by inserting the productΔ
amplified using primers N-Myc 1F and CT-Trun 1R corresponding to amino acids 39 to 326. SpARC4 lacking the N-terminal 17 amino
acids from the mature SpARC4 (SpARC4 N ) was generated by inserting the product amplified using primer N-Myc 2F and 6RΔ myc 
corresponding to amino acids 56 to 343. Plasmids encoding for SpARC4 , SpARC4 , and SpARC4 wereR52A/R53A myc Y142W myc Y142H myc 
constructed using the QuikChange site directed mutagenesis kit (Stratagene) with pCS2  SpARC4 as the template and the following+ myc 
mutagenic primers: R52,53A_sense/R52,53A_antisense, Y142W_sense/Y142W_antisense and Y142H_sense/Y142H_antisense. All
constructs were verified by DNA sequencing. The sequences of the primers used are listed in and a schematic of the constructs isTable S1 
presented in .Fig. 2B 
Sequence analysis
Sequences were aligned using Clustal-W. Signal peptides/anchors were predicted by SignalP 3.0. GPI modification site was identified
by big-PI predictor and GPI-SOM. N-glycosylation sites were predicted by NetNGlyc 1.0. The pro-protease cleavage site was predicted by
ProP 1.0.
Microinjection of Xenopus laevis embryos
embryos at the 2 4 cell stage were injected with 0.8 ng of mRNA per blastomere and cultured in 5  normal amphibianXenopus – %
medium ( ) at 14 C until the late blastula/early gastrula stage. For immunocytochemistry only a single blastomere was injected in order61 °
to induce mosaic expression.
Transfection of HEK cells
Human embryonic kidney (HEK) cells were grown and maintained in DMEM supplemented with 10  serum, penicillin (100 U/ml)%
and streptomycin (100 g/ml) at 37 C in a humidified 5  CO chamber. The cells were seeded in an antibiotic-free medium 24 h prior toμ ° % 2 
transfection on either 6 well plates (for western blotting/secretion assays) or 24-well plates containing poly-L-Lysine (20 g/ml) coated 1μ
cm diameter coverslips (for immuno-cytochemistry). Upon reaching 90  confluency, the cells were transiently transfected with plasmid%
DNA using Lipofectamine 2000 transfection reagent (Invitrogen) according to manufacturer s instructions. Cells were used 17 hours’
post-transfection.
Preparation of homogenates
For Western blot analysis, homogenates were prepared at 4 C in a buffer composed of 20 mM Tris, HCl pH 7.2, 50 mM NaCl, 10 mM°
MgAcetate and 1  Triton X-100. For embryos, the embryos were resuspended at a ratio of 20 l of buffer/embryo, incubated for% Xenopus μ
30 min and the supernatant collected following centrifugation at 21,000xg for 1 min. For HEK cells, cells were resuspended at a ratio of
100 l of buffer/confluent well of a 6-well plate, incubated for 60 min and the supernatant collected following centrifugation at 100,000xgμ
for 60 min. For enzyme activity measurements, embryos were homogenised in a hypotonic buffer (20 mM HEPES, pH 7.2 withXenopus 
complete EDTA free protease inhibitors), followed by three 5 sec bursts of sonication at 4 C. The homogenates were stored at 20 C in ™ ° − °
single use aliquots until required.
Enzyme treatments
For deglycosylation experiments, embryo homogenates (half embryo equivalents) were denatured and treated with or without
PNGaseF (New England Biolabs) according to manufacturer s instructions. For PI-PLC treatment, adherent HEK cells were incubated’
either in the absence or presence of 1 U/ml PI-PLC (Sigma) at 37 C for 1 h in HEPES-buffered saline composed of 156 mM NaCl, 3mM°
KCl, 2 mM MgSO , 1.25 mM KH PO , 10 mM D-Glucose, 2 mM CaCl and 10 mM HEPES (pH 7.4). The medium was then collected4 2 4 2 
and concentrated 10-fold using an Amicon Ultra 4 centrifugal filter (10 kDa cut-off).
Secretion assays
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HEK cells were transfected with plasmids encoding SpARC4 or SpARC4 C and the media replaced with serum andmyc Δ myc 
antibiotic free media, 5 h post-transfection. Cells were cultured for 12 15 h before preparation of cell homogenates and collection of–
media. The latter were concentrated 10-fold using Amicon Ultra 4 centrifugal filter (10 kDa cut-off).
Western blot analysis
X embryo homogenates (0.33 equivalents) or HEK cell homogenates (25 50 g protein), or media were reduced and denaturedenopus – μ
with 4 mM DTT at 90 C for 10 min and loaded onto NuPAGE 4 12  Bis-Tris gels (Invitrogen). The gel was run with either MOPS or° – %
MES running buffer (Invitrogen) and the resolved proteins transferred to a nitrocellulose membrane (Applied Biosystems). The blots were
blocked with 5  dried skimmed non-fat milk powder dissolved in Tris-buffered saline (25 mM Tris, HCl 137 mM NaCl, 2.7 mM KCl, pH%
7.4) supplemented with 0.1  Tween-20 (TBS-T) overnight at 4 C. The blot was washed 3 times with TBS-T and incubated with the% °
primary antibody (mouse anti-Myc monoclonal antibody, clone 9e10; Insight Biotechnology; 1/1000 dilution) for 1 h at 25 C. Following a°
further 3 washes with TBS-T, the blot was incubated with the secondary antibody (anti-mouse IgG conjugated to horse radish peroxidase;
Invitrogen; 1/1000 dilution) for 1 h at 25 C. The blots were developed either with Pierce ECL substrate (Thermo Scientific) or ECL°  ™
Advanced System (GE Healthcare) according to manufacturer s guidelines’
Immunocytochemistry
embryos were fixed with 4  paraformaldehyde in phosphate-buffered saline (PBS) and stored at 4 C. The embryos wereXenopus % °
then permeabilised by 2 washes with Tris-buffered saline containing 0.1  Triton X-100 followed by 3 washes with TBS-T (30 min each).%
The embryos were then blocked with 20  goat serum in TBS-T for 1 h at room temperature. Embryos were incubated with the primary%
antibody (mouse anti- monoclonal antibody, clone 9e10; 1/100 dilution) overnight at 4 C in blocking solution. The embryos were thenmyc °
washed 4 times with TBS-T containing 2 mg/ml BSA and blocked again in a solution containing TBS-T supplemented with 2 mg/ml BSA
and 20  goat serum for 1 h. Embryos were incubated with the secondary antibody (goat polyclonal anti-mouse IgG conjugated with Cy-3;%
Zymed; 1/100 dilution) overnight at 4 C in the same blocking solution. The embryos were then washed 4 times with TBS-T containing 2°
mg/ml BSA (30 min each).
For transfected HEK cells, cells were fixed in 4  paraformaldehyde in phosphate-buffered saline (PBS) for 10 min at 25 C followed% °
by 3 washes with PBS at 25 C. The cells were permeabilised with PBS  0.1  TX-100 for 10 min at 25 C with gentle agitation. The cells° + % °
were then washed again (3 times with PBS) and incubated with blocking solution (5  foetal bovine serum and 1  bovine serum albumin% %
in PBS) for 60 min at 25 C with gentle agitation. The coverslips were incubated with primary antibody (mouse monoclonal anti- 9e10;° myc 
1/100 dilution) in blocking solution at 37 C for 60 min followed by 3 washes with PBS  0.1  Tween-20). The coverslips were then° + %
incubated with the secondary antibody (goat polyclonal anti-mouse IgG conjugated with Cy-3; 1/100 dilution) in blocking solution at 37 C°
for 60 min followed by 3 washes with PBS  0.1  Tween-20. The coverslips were mounted on glass slides with DABCO, air dried and+ %
sealed with nail varnish. In some experiments, immunocytochemistry was performed using non-permeabilised cells. In these cases, live
cells were incubated with the primary antibody in HEPES-buffered saline for 60 min at 4 C. The cells were then fixed, washed with PBS°
and incubated with the secondary antibody as described above.
Confocal microscopy
Fluorescence images of embryos and HEK cells were captured using a Zeiss LSM 510 confocal microscope equipped with aXenopus 
20x or 63x objective. The wavelengths for excitation and emission for Cy3 were 543 nm and 560 615 nm, respectively.–
Enzyme activity measurements
embryo homogenates (typically 20 l) were diluted 5-fold into reaction mixes composed of either 1 mM NAD and 20 mMXenopus μ
HEPES (pH 7.2), for the measurement of ADP-ribosyl cyclase activity or 1 mM NADP and 50 mM nicotinic acid (pH 4.8), for the
measurement of base-exchange activity. The reactions were allowed to proceed for up to 4h at room temperature, diluted 10-fold with
water and heated at 60 C for 5 min. The mix was then centrifuged for 1 min at 21000  g to remove any particulate matter. The° ×
supernatants were injected onto an AGMPI (Biorad) anion exchange HPLC column (3 150mm) at a flow rate of 1ml/min and bound×
nucleotides separated with a concave-up gradient of trifluoroacetic acid as described previously ( ). Absorbance was recorded at 254 nm25 
using a UV spectrophotometer and the areas of the resolved peaks calculated using Breeze Software (Waters). A mix of standards (1mM
NAD, NADP, cADPR, NAADP) was separated in parallel for calibration.
RESULTS
Our original BLAST queries of the genome with known ADP-ribosyl cyclase sequences led to theStronglyocentrotus purpuratus 
isolation of SpARC1-3 ( ). Here we report the molecular cloning of a new ADP-ribosyl cyclase herein named SpARC4. The full-length25 
coding sequence was determined using a combination of 5 - and 3 -RACE (See Methods). SpARC4 is predicted to encode a polypeptide′ ′
comprising 343 amino acids. An alignment of the deduced amino acid sequence of SpARC4 with those of SpARC1-3 is shown in Figure
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. Sequence identity between SpARC4 and other family members was ~ 25  and sequence similarity was ~ 40  ( ). We also1A % % Figure 1B 
identified three ESTs from the sea urchin that were 65 66  identical and 74  similar to SpARC4 ( ). TheParacentrotus lividus – % % Fig. S1 
10 core  cysteine residues found in ADP-ribosyl cyclase are conserved in SpARC4 ( , asterisks). These data further“ ” Aplysia Fig. 1A 
highlight expansion of the ADP-ribosyl cyclase family.
SpARC4 is predicted to have an N-terminal signal peptide of 34 residues, 3 N-linked glycosylation sites (1 within the putative signal
peptide) and a C-terminal GPI anchor ( ). The predicted structure of SpARC4 is schematically depicted in . In order toFig. 1A Figure 2A 
define the properties of SpARC4, the series of expression constructs represented in were generated. We first expressed theFig. 2B 
full-length -tagged SpARC4 (SpARC4 ) in embryos and HEK cells ( ). Western blot analysis using an anti-myc myc Xenopus Fig. 2C myc 
antibody revealed the presence of a major polypeptide of ~55 kDa in embryos expressing SpARC4 ( ). The apparent molecularmyc Fig. 2C 
mass of SpARC4 was modestly reduced following treatment of homogenates with PNGase-F, which releases N-linked glycans (myc Fig.
). The size of the PNGase-F-treated protein was in reasonable agreement with the predicted molecular mass of mature SpARC4 2C myc 
(44 kDa). In HEK cells expressing SpARC4 , two major bands of approximately 55 kDa and 45 kDa were observed ( ).myc Fig. 2C 
Treatment with PNGase-F reduced the apparent molecular mass of the larger band but the migration of the lower band was not affected.
The identity of the latter remains to be established but may correspond to unprocessed SpARC4. These data indicate that SpARC4 is
N-glycosylated, consistent with the presence of consensus N-glycosylation sites.
To determine the subcellular localisation of SpARC4, we performed immunocytochemical analysis in conjunction with confocal
microscopy. shows the distribution of SpARC4 expressed in embryos. Two patterns were observed; clear cellFig. 2D myc Xenopus 
surface staining ( , top left), or a punctate intracellular distribution often concentrated at the periphery ( , top right). In theseFig. 2D Fig. 2F 
experiments, only a single blastomere of a 2 4 cell embryo was injected in order to effect mosaic expression. Indeed, cells which did not–
express the protein were clearly evident in embryos ( , asterisks) thereby defining background staining and thus attesting toFig. 2D 
specificity of the labelling. In HEK cells, SpARC4 localized mainly to the plasma membrane although diffuse intracellular staining was
also evident ( , bottom left). Localisations were also performed using intact (non-permeabilized) cells ( , bottom right).Fig. 2D Fig. 2D 
Surface staining was readily detectable indicating that the epitope is extracellular further confirming plasma membrane residence of this
protein.
Given the consensus sequence for GPI anchoring, we next examined the effect of bacterial phosphatidyl inositol-specific
phospholipase C (PI-PLC), which releases GPI-anchored proteins from the plasma membrane. We first treated cells expressing SpARC4 
with PI-PLC and analysed the media for SpARC immunoreactivity by Western blotting. As shown in , this treatment resultedmyc Fig. 3A 
in the appearance of released SpARC4 in the medium. These data suggest that SpARC4 is attached to the plasma membrane by a GPImyc 
anchor. In parallel experiments, we examined cell surface expression of SpARC4 by immunocytochemistry. As shown in ,myc Fig. 3B 
PI-PLC treatment caused a reduction in expression of SpARC4, again consistent with the presence of a GPI-anchor. Finally, we deleted the
C-terminus harbouring the putative GPI anchoring site and compared secretion of the full-length and truncated SpARC4 . As shownmyc 
in , SpARC4 C was present in the medium at higher levels than the full-length construct. Both constructs were expressed atFig 3C Δ myc 
comparable levels within cells (data not shown). These data suggest that SpARC4 is attached to the plasma membrane at its C-terminus via
a GPI anchor.
We have previously used an HPLC assay and embryos over-expressing SpARC1 and SpARC2 to characterize the enzymaticXenopus 
properties of the heterologously translated proteins ( ). Here we use the same approach to characterize SpARC4. In the first set of25 
experiments, homogenates expressing SpARC4 were incubated with NAD. As shown in the HPLC chromatogram in , NAD,myc Fig 4A 
after a 3 h incubation, was converted to a product with retention time of 17.7  0.14 min corresponding to that of cADPR (17.3  0.1 min).± ±
ADP-ribose production was not routinely detected (retention time  26 min) under these experimental conditions. We next tested whether=
SpARC4 could generate NAADP. For these experiments, homogenates were incubated with NADP and nicotinic acid under acidic
conditions to favour the base-exchange reaction. As shown in , NADP, after a 3 h incubation, was converted to a productFig. 4B 
(retention time  31.4  0.04 min) that co-eluted with NAADP (retention time  31.3  0.03 min). Thus, SpARC4 is capable of both the= ± = ±
cyclisation and base-exchange reactions indicating that it is a multifunctional ADP-ribosyl cyclase.bona fide 
A time-course for cADPR and NAADP production by SpARC4 is shown in . Strikingly, SpARC4 produced markedlyFig. 4C myc 
more cADPR than NAADP under these experimental conditions of saturating substrate concentrations. This is in direct contrast to
SpARC1 and SpARC2 which, as previously reported ( ), produce more NAADP than cADPR when assayed identically. The results with25 
SpARC2 are confirmed here ( ). The initial rates of cADPR and NAADP production are listed in . SpARC4 untagged alsoFig. 4D Table 1 
displayed the same preference for producing cADPR as SpARC4 ( ), indicating that the unusual catalytic activity associatedmyc Table 1 
with SpARC4 was not a consequence of tagging the protein.
Inspection of the sequence downstream of the predicted signal peptide of SpARC4, revealed the presence of a cluster of acidic amino
acids followed by basic residues ( , box). This acidic-basic cluster is unique to SpARC4 among ADP-ribosyl cyclases. ToFig. 1A 
investigate the potential functional role of this cluster, we generated a construct in which the sequence was deleted (SpARC4 N ).Δ myc 
Molecular determinants of cADPR and NAADP production.
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This construct like the full-length construct was readily expressed in both embryos and HEK cells ( ).Xenopus Fig. 5A 
Immunocytochemical analysis indicated that it localised to the plasma membrane ( ). Measurement of cADPR and NAADPFig. 5B 
production did not reveal any differences between SpARC4 N and SpARC4 . ( ). Thus, SpARC4 N alsoΔ myc myc Fig. 5C Δ myc 
preferentially produced cADPR ( , ). We noted that the basic amino acids within the unique region of SpARC4 conform toFig. 5C Table 1 
a consensus sequence (RXXR) for cleavage by pro-convertase, raising the possibility that SpARC4 may be proteolytically processed.
However, we could not detect the putative N-terminal cleaved product containing the tag (predicted size ~ 15 kDa) by Westernmyc 
blotting when gels were run under conditions to optimally resolve small proteins and when the blots were over developed ( ).Fig. 5D 
Additionally, a mutant construct (SpARC4 ), in which arginine 52 and 53 were replaced with alanine (to disrupt theR52A/R53A myc 
consensus cleavage site), was readily expressed ( ), localized to the plasma membrane ( ) and catalytically similar toFig. 5A Fig. 5B 
SpARC4 ( , ). Taken together, the acidic-basic cluster appears not to affect the catalytic properties of SpARC4.myc Fig 5C Table 1 
Several residues that form the active site of ADP-ribosyl cyclase, CD38 and CD157 have been identified by site directedAplysia 
mutagenesis and structural studies. These include a tryptophan residue (at position 77 and 125 in and human CD38, respectively)Aplysia 
which is strictly conserved in these ADP-ribosyl cyclases ( ; ). Intriguingly, multiple sequence alignment identifies a tyrosine residue48 49 
at the corresponding position 142 of SpARC4, suggesting that this enzyme, in analogy with NACE ( ) possesses aSchistosoma mansoni 24 
non-canonical active site ( ). To assess the potential functional importance of tyrosine 142, we generated a mutant construct inFig. 6A 
which this residue was replaced with tryptophan (SpARC4 ). We also generated a second construct in which tyrosine wasY142W myc 
replaced with histidine (SpARC4 ). The latter mutation corresponds to the residue found in NACE ( ). Both mutantY142H myc Sm Fig. 6A 
constructs were readily expressed in embryos and HEK cells to comparable levels as the wild type construct ( ).Xenopus Fig. 6B 
Additionally, both mutant constructs localized to the plasma membrane ( ). Production of cADPR and NAADP for the twoFig. 6C 
constructs is shown in . Remarkably, whereas the wild type construct preferentially produced cADPR, production of cADPR andFig. 6D 
NAADP was comparable for SpARC4 ( ). Overall activity, however, was reduced relative to the wild type enzyme (Y142W myc Fig. 6D 
). These data highlight a critical role for tyrosine 142 in determining both the catalytic efficiency of SpARC4 and the relativeTable 1 
production of cADPR and NAADP. The results with SpARC4 were even more striking. This single mutation greatly affected theY142H myc 
ADP-ribosyl cyclase activity of SpARC4 without perturbing the transglycosidation process ( ). Thus, there was a complete reversalFig. 6D 
in the preference for the different reactions such that the mutant cyclase preferentially produced NAADP ( , ), very muchFig. 6D Table 1 
like SpARC2 ( ). The ratio of the initial rates of cADPR and NAADP production for the different constructs from severalFig. 4D 
independent preparations is summarized in . This analysis has the advantage in that it is independent of the absolute expressionFig. 7 
levels of the constructs, which varies between preparations. These data show that production of cADPR and NAADP by SpARC4 is
controlled by a single active site residue, which, when mutated, can convert SpARC4 into a SpARC2-like enzyme.
DISCUSSION
In the present study, we report the molecular cloning of an additional member of the ADP-ribosyl cyclase family, show that it is a
glycoprotein targeted to the plasma membrane by a GPI-anchor and that it displays unusual catalytic activity dictated by a single active site
residue.
Our understanding of the molecular diversity of ADP-ribosyl cyclases is currently limited. and (protostomes)Aplysia Schistosoma 
possess a single ADP-ribosyl cyclase gene whereas mammals (deuterostomes) possess two. The sea urchin holds a key evolutionary
position as a basal deuterostome and as a close relative of the chordates. We have previously characterized an expanded three member
family of ADP-ribosyl cyclases in the sea urchin ( ). Here we highlight further expansion of this family through the cloning of a fourth25 
member, SpARC4. Comparative genomic analysis of ADP-ribosyl cyclases in other deuterostomes should provide insight into the unusual
evolution of the ADP-ribosyl cyclase gene family in this lineage.
SpARC4, like SpARC2 ( ), mammalian CD157 ( ) and NACE ( ), localizes to the plasma membrane via a GPI-anchor (55 23 Sm 24 
), which contrasts to the intracellular location of SpARC1 ( ). The ecto-cellular location of SpARC4 shared also byFigs. 2 –3 25 
mammalian CD38 ( ) further suggests that second messenger production may occur at extra-cellular sites. Whether SpARC4 (and22 
SpARC2) is internalized, e.g. via endocytosis, as reported for CD38 ( ) remains to be established, although we did note a punctate62 
intracellular distribution of SpARC4 in some cells upon heterologous expression in embryos which might indicate an endosomalXenopus 
location ( ).Fig. 2 
A clear distinguishing feature of SpARC4 relates to its catalytic activity; under our experimental conditions, SpARC4 appears to
produce predominantly cADPR ( ), whereas SpARC1 and SpARC2 preferentially produce NAADP ( ; ). An unidentifiedFig. 4 25 55 
enzyme present on the surface of sea urchin sperm also preferentially produces NAADP ( ). Whilst much attention has focused on63 
determining the relative rates of NAD cyclisation and glycohydrolase activity culminating recently in the effective interconversion of
CD38 and ADP-ribosyl cyclase by site-directed mutagenesis ( ), little is known about what controls the relative production ofAplysia 58 
cADPR and NAADP.
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Elucidating the molecular basis for the pronounced difference in catalytic activity between SpARC4 and other family members
represents a formidable challenge given the very modest sequence identity between them ( ). We first focused on a cluster of acidicFig. 1B 
and basic amino acids in the N-terminus of SpARC4. This cluster is absent from other SpARCs. Interestingly, this region of the protein
encompasses a consensus pro-convertase cleavage sequence raising the possibility that SpARC4 may be proteolytically processed, which
in turn may regulate catalysis. Indeed, cleavage at such sites in many other proteins including tolloid metalloproteases is required for
activity ( ). However as shown in , we could not detect cleavage of SpARC4 despite the presence of robust pro-protease activity64 Fig. 5D 
in embryos ( ; ). Moreover, catalytic activity of SpARC4 was unaffected when the putative cleavage site was disrupted byXenopus 65 66 
site directed mutagenesis or when the N-terminus encompassing the site was deleted ( ). Thus, this region of the enzyme appears toFig. 5C 
not affect catalysis. Its functional role remains to be defined.
Catalysis is thought to proceed via a partitioning kinetic mechanism ( ; ; ) raising the possibility that active site residue(s) may13 14 50 
control the cyclisation step relative to the base-exchange pathway. We therefore next focused on position 142 in SpARC4 where a tyrosine
residue replaces tryptophan which is otherwise strictly conserved in the enzyme, CD38 and CD157. This substitution wasAplysia 
confirmed by ESTs from a different urchin species ( ) indicating that a fourth ADP-ribosyl cyclase is not unique to the purple seaFig. S1 
urchin, and that the difference in sequence at this position was not due to a cloning error. The non-canonical active site described here for
SpARC4 is also a feature of NACE ( ). In NACE, the active site contains a histidine residue (His103) in place of this conservedSm 24 Sm 
tryptophan which in the other ADP-ribosyl cyclases has been implicated in substrate positioning ( ; ). In the enzyme and48 49 Aplysia 
CD38, mutation of this residue substantially affects both ADP-ribosyl cyclase and base-exchange activity. Notably, studies on CD38
included mutation of tryptophan 125 to tyrosine thus producing a mutant enzyme similar to SpARC4 ( ). Conversely, the ADP-ribosyl49 
cyclase activity of NACE, which is undetectable with NAD as substrate, was dramatically increased upon mutation of theSm 
non-canonical active site histidine 103 to tryptophan ( ). This effect was ascribed to the more polar environment in the wild-type enzyme60 
favouring entry of water and thus hydrolysis of NAD, as opposed to the competing intramolecular cyclisation of NAD ( ). In contrast,60 
SpARC4 displays robust ADP-ribosyl cyclase activity relative to other SpARCs and is more active than its tryptophan mutant ( ).Fig. 6 
These data suggest that other residues are likely to contribute to catalysis in SpARC4.
Despite the conservative nature of the substitution at the active site of SpARC4 (tryptophan to tyrosine), we show that this residue
plays a critical role in determining the production of cADPR over NAADP. This is most pronounced in SpARC4 , where theY142H 
ADP-ribosyl cyclase activity was decreased by one order of magnitude but, in sharp contrast with SpARC4 , the mutation did notY142W 
affect the transglycosidation reaction. Consequently a complete switch in relative ADP-ribosyl cyclase and base-exchange activity is
observed resulting in a catalytic profile very similar to SpARC1 and SpARC2 ( ). Previous mutagenesis analyses of Fig. 6 Aplysia 
ADP-ribosyl cyclase and CD38 have generally focused on cyclase/glycohydrolase ratios and, where measured, base-exchange activity of
the mutants tended to mirror changes in cyclase activity. One notable exception is glutamate 146 in CD38, which when mutated did in
some instances (e.g E146D and E146G) result in reciprocal changes in cyclase and base-exchange activity ( ). Thus, this residue might59 
also dictate the relative production of cADPR and NAADP.
The non-canonical active sites of NACE and SpARC4 are highly unusual. The presence of residues other than tryptophan at thisSm 
position in ADP-ribosyl cyclases appears unique to these enzymes based on inspection of a variety of ADP-ribosyl cyclase sequences
across phyla (data not shown). Thus, selection pressure appears to have been relaxed for these homologues. The resulting changes in
activity in the sea urchin might be of particular significance given the multiplicity of isoforms in this organism. We speculate that different
ADP-ribosyl cyclase isoforms with different activities might regulate specific cellular functions.
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Figure 1
Molecular cloning of a novel member of the ADP-ribosyl cyclase family
A, Multiple sequence alignment of the deduced amino acid sequences of SpARC4 and that of previously identified ADP-ribosyl cyclases from
(SpARC1-3). Putative cleavage sites of the predicted signal peptide and GPI-anchor are marked with the filledStrongylocentrotus purpuratus 
and open arrow heads, respectively. The presence of an acidic-basic cluster of amino acids in SpARC4 is marked with a box. Conserved
cysteine residues between isoforms are marked with an asterisk. B, Table showing percentage sequence identities (shaded) and percentage
sequence similarities (above diagonal) derived from pair-wise alignments between SpARC family members.
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Figure 2
SpARC4 is a glycoprotein targeted to the plasma membrane
A, Predicted structure of SpARC4. Putative N-linked glycosylation sites are marked with a Y . B, Schematic of the constructs used in this“ ”
study. C. Western blot analysis, using an anti- antibody, of embryos (left) or HEK cells (right) expressing -tagged SpARC4myc Xenopus myc 
(SpARC4 ). Samples were untreated ( ), mock treated or digested with PNGase F prior to analysis. Migration of molecular mass markersmyc −
(in kDa) is shown on the left of the panel. D, Confocal fluorescence images of embryos (top) or HEK cells (bottom)Xenopus laevis 
expressing SpARC4 . Expression was detected by immunocytochemistry using an anti- primary antibody. For embryos, the imagesmyc myc 
are typical of the two distribution patterns observed. The asterisks highlight cells not expressing the protein. For HEK cells, both
permeabilized and non-permeabilized cells were processed. Scale bar  5 m.= μ
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Figure 3
SpARC4 is a GPI-anchored protein
HEK cells expressing SpARC4 were treated with ( ) or without ( ) PI-PLC and the presence of SpARC4 determined in media samplesmyc + −
by Western blot analysis (A) and on the cell surface by immunocytochemistry (B). Scale bar  50 m. C, Western blot analysis of media= μ
samples from HEK cells expressing SpARC4 or myc-tagged SpARC4 lacking the C-terminal 17 amino acids (SpARC4 C ).myc Δ myc 
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Figure 4
SpARC4 is a multifunctional ADP-ribosyl cyclase
A B, Homogenates prepared from embryos expressing SpARC4 were incubated with 1 mM NAD (A) or 1 mM NADP  50– Xenopus myc +
mM nicotinic acid (B) and the reaction mixes separated by HPLC. Typical chromatograms after a 0.1 h (black traces) or 3 h (red traces)
incubation are shown. C D. Time courses for production of cADPR (circles) and NAADP (squares) by embryo homogenates– Xenopus 
expressing SpARC4 (C) and SpARC2 (D)myc myc 
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Figure 5
Lack of effect of the acidic-basic cluster on SpARC4 activity
A, Western blot analysis of embryos (left) or HEK cells (right) expressing -tagged SpARC4 lacking either the N-terminal 17Xenopus myc 
amino acids (SpARC4 N ) or in which arginines 52 and 53 were mutated to alanine (SpARC4 ). SpARC4 wasΔ myc R52A/R53A myc myc 
analyzed in parallel. B, Immunocytochemical localisation of SpARC4 N and SpARC4 in HEK cells. Scale bar  5 m. C,Δ myc R52A/R53A myc = μ
Time-courses for production of cADPR and NAADP by SpARC4 , SpARC4 N and SpARC4 D, Western blotmyc Δ myc R52A/R53A myc. 
analysis of SpARC4 and SpARC4 . Arrow head marks the expected migration of the putative cleavage product. Blots weremyc R52A/R53A 
deliberately overexposed.
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Figure 6
Regulation of SpARC4 activity by non-canonical active site residue
A, multiple sequence alignment of ADP-ribosyl cyclases showing lack of conservation of an active site tyrosine (asterisk) in SpARC4 and 
ADP-ribosyl cyclase. Abbreviations used: Ac, ; Hs, ; Sm, ; Sj, Schistosoma Aplysia californica Homo sapiens Schistosoma mansoni 
. B, Western blot analysis of embryos (left) or HEK cells (right) expressing SpARC4 -taggedSchistosoma japonica Xenopus myc or myc 
SpARC4 in which tyrosine 142 was mutated to either tryptophan (SpARC4 ) or histidine (SpARC4 ). C,Y142W myc Y142H myc 
Immunocytochemical localisation of SpARC4 and SpARC4 in HEK cells. Scale bar  5 m. D, Time-courses forY142W myc Y142H myc = μ
production of cADPR and NAADP by SpARC4 , SpARC4 and SpARC4myc Y142W myc Y142H myc.
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Figure 7
Summary of mutational analysis on SpARC4 activity
Pooled data showing the ratio of ADP-ribosyl cyclase to base-exchange activity for the indicated construct. Data are presented as mean ±
standard error of the mean from 3 6 independent embryo preparations.– Xenopus 
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Table 1
Initial rates of cADPR and NAADP production. Data are presented as mean  standard error of the mean from the indicated number of independent embryo preparations.± Xenopus 
Construct cADPR production (nmoles/h/embryo) NAADP production (nmoles/h/embryo) n
SpARC4 myc 2.61  0.49± 0.77  0.16± 9
SpARC4 untagged 2.96  1.19± 1.02  0.51± 3
SpARC4 N Δ myc 3.9  0.85± 1.36  0.32± 3
SpARC4R52A/R53A myc 2.19  0.42± 0.97  0.09± 3
SpARC4Y142W myc 0.13  0.02± 0.15  0.03± 3
SpARC4Y142H myc 0.1  0.04± 1.06  0.24± 3
SpARC2 myc 0.05  0.01± 0.39  0.07± 6
